| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $5.4M | -2.4% | +57.4% |
| SG&A Expense | $3.9M | +9.7% | +30.5% |
| Operating Income | -$9.3M | -2.3% | -44.9% |
| Pre-tax Income | -$8.7M | -3.2% | -20.2% |
| Income Tax | $0 | — | — |
| Net Income | -$8.7M | -3.2% | -20.2% |
| EPS (Basic) | -$0.07 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $51.8M | -10.4% | -30.7% |
| Current Assets | $55.7M | -10.9% | -27.8% |
| Total Assets | $58.0M | -10.1% | -27.0% |
| Current Liabilities | $8.2M | +20.6% | +41.9% |
| Total Liabilities | $8.2M | +20.6% | +41.9% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.2M | — | — |
| Capital Expenditures | $16K | — | — |
| Investing Cash Flow | -$16K | — | — |
| Financing Cash Flow | $0 | — | — |
| Free Cash Flow | -$19.2M | — | — |
| -16.7% |
| EPS (Diluted) | -$0.07 | +0.0% | -16.7% |
| $49.8M |
| -13.7% |
| -32.4% |